Skip to main content
. 2023 Oct 23;31(1):614–621. doi: 10.1245/s10434-023-14422-2

Table 5.

Cohort comparison of patients treated with repeat CRS/HIPEC versus chemotherapy alone

Chemotherapy alone (n = 36) Repeat CRS/HIPEC (n = 50) p value
Age (years) (median, IQR) 58 (52–62) 53 (33–61) 0.02
Female gender (n, %) 22 (61%) 38 (63%) 0.16
Grade (n, %)
 Well differentiated 9 (21%) 33 (66%) < 0.001
 Moderately differentiated 12 (33%) 12 (24%)
 Poorly differentiated 15 (42%) 5 (10%)

Bold indicates statistically significant finding